Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEECH: Capivasertib + Paclitaxel in Advanced Breast Cancer
NCT01625286Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of capivasertib in breast cancer, sponsored by AstraZeneca. Started Oct 2012; status: completed.
02
Drugs
capivasertib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01625286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625286.